Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
601827 Chongqing Sanfeng Environment Group Corp.,
- 8.55
- +0.12+1.42%
Not Open Apr 1 15:00 CST
14.30BMarket Cap12.23P/E (TTM)
8.60High8.42Low64.11KlotVolume8.44Open8.43Pre Close54.64MTurnover0.38%Turnover Ratio12.23P/E (Static)1.67BShares9.6952wk High1.28P/B14.30BFloat Cap7.3552wk Low9.27Limit Up1.67BShs Float11.16Historical High7.59Limit Down2.14%Amplitude5.77Historical Low0.24Dividend TTM8.52Avg Price27.53KlotAsk2.75%Div YieldTTM100Lot Size35.49KlotBid
Chongqing Sanfeng Environment Group Corp., Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.59%5.99B | -0.47%4.52B | 5.08%3.13B | 0.42%1.55B | 0.06%6.03B | 6.52%4.54B | 4.30%2.98B | 0.06%1.55B | 2.54%6.02B | -4.70%4.26B |
| Operating revenue | -0.59%5.99B | -0.47%4.52B | 5.08%3.13B | 0.42%1.55B | 0.06%6.03B | 6.52%4.54B | 4.30%2.98B | 0.06%1.55B | 2.54%6.02B | -4.70%4.26B |
| Other operating revenue | 78.90%11.39M | ---- | 262.44%7.55M | ---- | -36.23%6.37M | ---- | 24.16%2.08M | ---- | 99.81%9.98M | ---- |
| Total operating cost | -3.12%4.77B | -3.62%3.44B | 0.74%2.4B | -5.05%1.13B | 0.79%4.92B | 5.44%3.57B | 6.32%2.39B | -2.31%1.19B | 4.06%4.88B | -0.39%3.38B |
| Operating cost | -2.66%4B | -4.21%2.9B | 1.35%2.05B | -5.00%974.61M | -0.76%4.11B | 4.79%3.03B | 4.90%2.03B | -3.61%1.03B | 3.32%4.14B | -2.11%2.89B |
| Operating tax surcharges | 7.35%77.68M | 8.69%56.27M | 8.64%38.25M | 14.61%17.92M | 13.57%72.36M | 14.88%51.77M | 24.09%35.21M | 10.50%15.63M | 15.10%63.71M | 8.97%45.07M |
| Operating expense | 3.79%22.77M | 11.06%11.91M | 6.47%7.47M | -3.82%3.05M | 3.99%21.94M | 1.27%10.73M | 0.12%7.01M | -9.55%3.17M | -21.86%21.1M | -30.26%10.59M |
| Administration expense | 1.09%313.45M | 15.67%220.23M | 15.32%137.85M | -0.84%53.5M | 17.61%310.08M | 10.08%190.4M | 12.94%119.54M | 10.85%53.96M | 11.51%263.65M | 14.41%172.96M |
| Financial expense | -6.15%286.15M | -1.47%222.34M | -2.29%147.11M | -9.80%72.79M | -3.91%304.91M | -1.65%225.67M | 1.59%150.56M | 6.79%80.7M | 11.35%317.33M | 12.36%229.46M |
| -Interest expense (Financial expense) | -6.45%303.61M | -1.17%237.61M | -1.27%159.11M | -2.27%67.9M | 8.79%324.56M | 10.74%240.42M | 17.77%161.15M | 1.87%69.47M | 10.72%298.34M | 12.86%217.11M |
| -Interest Income (Financial expense) | -18.01%-19.37M | 9.89%-16.75M | 11.79%-12.55M | -80.01%-6.17M | -54.60%-16.41M | -139.35%-18.59M | -845.85%-14.23M | -26.20%-3.43M | 42.11%-10.61M | 27.41%-7.77M |
| Research and development | -35.13%63.85M | -53.04%30.07M | -59.43%19.13M | -25.92%7.22M | 37.62%98.43M | 65.55%64.04M | 106.65%47.15M | -10.71%9.75M | -6.11%71.52M | 7.74%38.68M |
| Credit Impairment Loss | -138.49%-93.58M | -1,061.45%-43.22M | -864.77%-39.29M | -188.70%-2.94M | -9.48%-39.24M | 92.58%-3.72M | 111.13%5.14M | 110.83%3.32M | -8.29%-35.84M | -5.82%-50.18M |
| Asset Impairment Loss | -365.21%-13.8M | -9.49%-34.7M | -70.50%-29.9M | -38.29%-23.3M | -129.23%-2.97M | -1,696.80%-31.69M | -404.98%-17.54M | -501.31%-16.85M | 246.75%10.15M | 12.86%1.98M |
| Other net revenue | -36.58%160.55M | -37.97%123.98M | -57.30%65.79M | -25.37%42.43M | 36.93%253.15M | 44.78%199.87M | 99.57%154.08M | 115.21%56.85M | -22.56%184.87M | -21.97%138.05M |
| Invest income | -3.16%130.31M | -2.31%98.2M | 0.02%63.15M | 10.22%31.07M | 5.18%134.56M | -9.57%100.52M | -16.38%63.13M | -15.23%28.19M | -38.93%127.93M | -34.15%111.17M |
| -Including: Investment income associates | -4.73%128.19M | -2.94%97.57M | 0.12%63.21M | 10.22%31.07M | 5.18%134.56M | -9.57%100.52M | -16.38%63.13M | -15.23%28.19M | -38.41%127.93M | -34.15%111.17M |
| Asset deal income | -45.19%-413.74K | 1,320.04%40.51K | 1,326.91%40.74K | 498.57%24.02K | -113.16%-284.96K | -100.16%-3.32K | -100.16%-3.32K | -100.32%-6.03K | 2,213.46%2.16M | 1,437.49%2.08M |
| Other revenue | -14.31%138.03M | -23.08%103.66M | -30.53%71.8M | -10.96%37.58M | 100.18%161.08M | 84.61%134.76M | 158.13%103.35M | 137.87%42.2M | 16.30%80.47M | 36.16%73M |
| Operating profit | 1.83%1.38B | 2.73%1.2B | 6.08%792.7M | 12.58%465.71M | 2.48%1.36B | 15.34%1.17B | 8.37%747.25M | 16.76%413.68M | -6.69%1.33B | -18.86%1.02B |
| Add:Non operating Income | 0.34%2.5M | -16.72%2.08M | -41.25%877.55K | -30.63%607.06K | -62.70%2.49M | -58.40%2.49M | -38.12%1.49M | 9.45%875.15K | -11.69%6.69M | 40.04%5.99M |
| Less:Non operating expense | -46.39%735.54K | -89.14%45.7K | -88.62%37.48K | 79.45%57.57K | 42.84%1.37M | 73.43%420.65K | 327.40%329.36K | 674.64%32.08K | 63.82%960.48K | 984.54%242.55K |
| Total profit | 1.88%1.39B | 2.72%1.2B | 6.03%793.54M | 12.48%466.26M | 2.13%1.36B | 14.89%1.17B | 8.17%748.41M | 16.74%414.52M | -6.74%1.33B | -18.68%1.02B |
| Less:Income tax cost | 12.75%162.75M | -2.97%138.4M | 4.99%91.39M | 29.45%56.86M | 6.87%144.35M | 17.10%142.64M | 6.92%87.05M | 12.07%43.92M | 13.52%135.07M | 6.81%121.81M |
| Net profit | 0.59%1.22B | 3.51%1.07B | 6.17%702.15M | 10.47%409.4M | 1.59%1.22B | 14.59%1.03B | 8.34%661.36M | 17.32%370.59M | -8.58%1.2B | -21.23%899.07M |
| Net profit from continuing operation | 0.59%1.22B | 3.51%1.07B | 6.17%702.15M | 10.47%409.4M | 1.59%1.22B | 14.59%1.03B | 8.34%661.36M | 17.32%370.59M | -8.58%1.2B | -21.23%899.07M |
| Less:Minority Profit | 9.67%55.21M | 23.62%56.35M | 25.53%35.86M | -6.30%19.34M | -12.94%50.34M | 17.15%45.59M | 36.59%28.57M | 89.36%20.64M | -18.72%57.83M | -14.58%38.91M |
| Net profit of parent company owners | 0.20%1.17B | 2.58%1.01B | 5.29%666.29M | 11.46%390.07M | 2.33%1.17B | 14.47%984.65M | 7.34%632.8M | 14.74%349.96M | -8.00%1.14B | -21.50%860.16M |
| Earning per share | ||||||||||
| Basic earning per share | 1.45%0.7 | 1.69%0.6 | 5.26%0.4 | 9.52%0.23 | 1.47%0.69 | 15.69%0.59 | 8.57%0.38 | 16.67%0.21 | -8.11%0.68 | -21.54%0.51 |
| Diluted earning per share | 1.45%0.7 | 1.69%0.6 | 5.26%0.4 | 9.52%0.23 | 1.47%0.69 | 15.69%0.59 | 8.57%0.38 | 16.67%0.21 | -8.11%0.68 | -21.54%0.51 |
| Other composite income | ||||||||||
| Total composite income | 0.59%1.22B | 3.51%1.07B | 6.17%702.15M | 10.47%409.4M | 1.59%1.22B | 14.59%1.03B | 8.34%661.36M | 17.32%370.59M | -8.58%1.2B | -21.23%899.07M |
| Total composite income of parent company owners | 0.20%1.17B | 2.58%1.01B | 5.29%666.29M | 11.46%390.07M | 2.33%1.17B | 14.47%984.65M | 7.34%632.8M | 14.74%349.96M | -8.00%1.14B | -21.50%860.16M |
| Total composite income of minority owners | 9.67%55.21M | 23.62%56.35M | 25.53%35.86M | -6.30%19.34M | -12.94%50.34M | 17.15%45.59M | 36.59%28.57M | 89.36%20.64M | -18.72%57.83M | -14.58%38.91M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.